HRP20041167A2 - Hidroxy tetrahydro-naphthalenylurea derivatives - Google Patents
Hidroxy tetrahydro-naphthalenylurea derivativesInfo
- Publication number
- HRP20041167A2 HRP20041167A2 HR20041167A HRP20041167A HRP20041167A2 HR P20041167 A2 HRP20041167 A2 HR P20041167A2 HR 20041167 A HR20041167 A HR 20041167A HR P20041167 A HRP20041167 A HR P20041167A HR P20041167 A2 HRP20041167 A2 HR P20041167A2
- Authority
- HR
- Croatia
- Prior art keywords
- tetrahydro
- pain
- hidroxy
- useful
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0210512.0A GB0210512D0 (en) | 2002-05-08 | 2002-05-08 | Tetrahydro-napthalene derivatives |
| GBGB0227262.3A GB0227262D0 (en) | 2002-05-08 | 2002-11-21 | Tetrahydro-naphthalene derivatives |
| PCT/EP2003/004395 WO2003095420A1 (en) | 2002-05-08 | 2003-04-28 | Hydroxy tetrahydro-naphthalenylurea derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20041167A2 true HRP20041167A2 (en) | 2005-08-31 |
Family
ID=29422108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20041167A HRP20041167A2 (en) | 2002-05-08 | 2003-04-28 | Hidroxy tetrahydro-naphthalenylurea derivatives |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7612113B2 (de) |
| EP (1) | EP1506167B1 (de) |
| JP (1) | JP4335131B2 (de) |
| CN (1) | CN1307150C (de) |
| AT (1) | ATE371641T1 (de) |
| AU (1) | AU2003229734B2 (de) |
| BR (1) | BR0309940A (de) |
| CA (1) | CA2487238C (de) |
| DE (1) | DE60315973T2 (de) |
| DK (1) | DK1506167T3 (de) |
| ES (1) | ES2292959T3 (de) |
| HR (1) | HRP20041167A2 (de) |
| IL (1) | IL165004A (de) |
| MX (1) | MXPA04010938A (de) |
| NO (1) | NO20045359L (de) |
| NZ (1) | NZ536418A (de) |
| PL (1) | PL210288B1 (de) |
| RU (1) | RU2331635C2 (de) |
| TW (1) | TWI271396B (de) |
| WO (1) | WO2003095420A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004028440A2 (en) * | 2002-09-24 | 2004-04-08 | Bayer Healthcare Ag | Vr1 antagonists for the treatment of urological disorders |
| CA2508618C (en) | 2002-12-06 | 2012-02-21 | Bayer Healthcare Ag | Tetrahydro-naphthalene derivatives |
| AU2003288200A1 (en) * | 2002-12-09 | 2004-06-30 | Bayer Healthcare Ag | Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists |
| EP1679296A4 (de) | 2003-10-14 | 2007-12-26 | Ajinomoto Kk | Etherderivat |
| EP1678123A1 (de) * | 2003-10-15 | 2006-07-12 | Bayer HealthCare AG | Tetrahydronaphthalin- und harnstoffderivate |
| WO2005044802A2 (en) * | 2003-11-08 | 2005-05-19 | Bayer Healthcare Ag | Tetrahydro-quinolinylurea derivatives as vrl antagonists |
| WO2005095329A1 (en) * | 2004-03-31 | 2005-10-13 | Pfizer Japan Inc. | Substituted benzamide compounds as vr1 receptor antagonists |
| EP1893189A2 (de) * | 2005-03-05 | 2008-03-05 | Bayer HealthCare AG | Verwendung von hydroxytetrahydronaphthalinderivaten zur behandlung von atemwegserkrankungen |
| AU2006225496A1 (en) | 2005-03-19 | 2006-09-28 | Amorepacific Corporation | Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| DE102005017286B3 (de) * | 2005-04-14 | 2006-12-28 | Schering Ag | Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
| DE102005023943A1 (de) | 2005-05-20 | 2006-11-23 | Grünenthal GmbH | Pentafluorsulfanyl-substituierte Verbindung und deren Verwendung zur Herstellung von Arzneimitteln |
| JP2010513557A (ja) * | 2006-12-20 | 2010-04-30 | アボット・ラボラトリーズ | 疼痛治療のためのｔｒｐｖ１バニロイド受容体アンタゴニストとしてのｎ−（５，６，７，８−テトラヒドロナフタレン−１−イル）尿素誘導体および関連化合物 |
| WO2008096755A1 (ja) * | 2007-02-07 | 2008-08-14 | Nippon Suisan Kaisha, Ltd. | バニロイド受容体（ｖｒ１）阻害剤及びその用途 |
| DE102009055915A1 (de) * | 2009-11-27 | 2011-06-01 | Beiersdorf Ag | Verwendung von Zingeron zur Herstellung kosmetischer oder dermatologischer Zubereitungen, welche auf der Haut ein Prickeln hervorrufen |
| WO2021039023A1 (ja) | 2019-08-23 | 2021-03-04 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の製造方法 |
| DE102022104759A1 (de) | 2022-02-28 | 2023-08-31 | SCi Kontor GmbH | Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9713484D0 (en) | 1997-06-27 | 1997-09-03 | Smithkline Beecham Plc | Neuroprotective vanilloid compounds |
| GB9727532D0 (en) * | 1997-12-23 | 1998-02-25 | Rh Ne Poulenc Rorer Limited | Chemical compounds |
| US6333337B1 (en) * | 1998-01-27 | 2001-12-25 | Icagen, Inc. | Potassium channel inhibitors |
| EP1154989B1 (de) * | 1999-02-22 | 2005-12-14 | Pacific Corporation | Vanilloid-analoge die resiniferatoxin-pharmacophore enthalten als wirksame vanilloid rezeptor agonisten und analgetika, zusammensetzungen und ihre verwendung |
| HUP0200996A3 (en) | 1999-04-07 | 2003-01-28 | Sankyo Company Ltd Chuo Ku | Amine derivatives, pharmaceutical compositions containing them and their use |
| US6294694B1 (en) | 1999-06-04 | 2001-09-25 | Wisconsin Alumni Research Foundation | Matrix metalloproteinase inhibitors and method of using same |
| CA2508618C (en) * | 2002-12-06 | 2012-02-21 | Bayer Healthcare Ag | Tetrahydro-naphthalene derivatives |
| EP1493438A1 (de) * | 2003-07-03 | 2005-01-05 | Bayer HealthCare AG | Inhibitoren des Vanilloid-Rezeptors (VR1) zur Behandlung von HIV-bedingten Schmerz |
| EP1678123A1 (de) * | 2003-10-15 | 2006-07-12 | Bayer HealthCare AG | Tetrahydronaphthalin- und harnstoffderivate |
| DE602004017892D1 (de) * | 2003-11-08 | 2009-01-02 | Bayer Healthcare Ag | Bicyclische amid-, carbamat- oder harnstoffderivate als modulatoren des vanilloidrezeptors |
-
2003
- 2003-04-28 EP EP03722554A patent/EP1506167B1/de not_active Expired - Lifetime
- 2003-04-28 MX MXPA04010938A patent/MXPA04010938A/es active IP Right Grant
- 2003-04-28 NZ NZ536418A patent/NZ536418A/en not_active IP Right Cessation
- 2003-04-28 HR HR20041167A patent/HRP20041167A2/xx not_active Application Discontinuation
- 2003-04-28 PL PL373257A patent/PL210288B1/pl unknown
- 2003-04-28 CA CA2487238A patent/CA2487238C/en not_active Expired - Lifetime
- 2003-04-28 WO PCT/EP2003/004395 patent/WO2003095420A1/en not_active Ceased
- 2003-04-28 JP JP2004503441A patent/JP4335131B2/ja not_active Expired - Lifetime
- 2003-04-28 CN CNB038159880A patent/CN1307150C/zh not_active Expired - Lifetime
- 2003-04-28 ES ES03722554T patent/ES2292959T3/es not_active Expired - Lifetime
- 2003-04-28 DK DK03722554T patent/DK1506167T3/da active
- 2003-04-28 AU AU2003229734A patent/AU2003229734B2/en not_active Expired
- 2003-04-28 US US10/513,848 patent/US7612113B2/en not_active Expired - Lifetime
- 2003-04-28 AT AT03722554T patent/ATE371641T1/de active
- 2003-04-28 BR BR0309940-7A patent/BR0309940A/pt not_active IP Right Cessation
- 2003-04-28 RU RU2004136281/04A patent/RU2331635C2/ru not_active IP Right Cessation
- 2003-04-28 DE DE60315973T patent/DE60315973T2/de not_active Expired - Lifetime
- 2003-05-07 TW TW092112380A patent/TWI271396B/zh not_active IP Right Cessation
-
2004
- 2004-11-03 IL IL165004A patent/IL165004A/en not_active IP Right Cessation
- 2004-12-07 NO NO20045359A patent/NO20045359L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1506167A1 (de) | 2005-02-16 |
| DE60315973T2 (de) | 2008-05-21 |
| ATE371641T1 (de) | 2007-09-15 |
| PL373257A1 (en) | 2005-08-22 |
| DK1506167T3 (da) | 2008-01-02 |
| JP2005524717A (ja) | 2005-08-18 |
| CN1665778A (zh) | 2005-09-07 |
| US20060258742A1 (en) | 2006-11-16 |
| MXPA04010938A (es) | 2005-02-14 |
| IL165004A (en) | 2010-12-30 |
| CA2487238A1 (en) | 2003-11-20 |
| US7612113B2 (en) | 2009-11-03 |
| PL210288B1 (pl) | 2011-12-30 |
| ES2292959T3 (es) | 2008-03-16 |
| TWI271396B (en) | 2007-01-21 |
| NO20045359L (no) | 2004-12-07 |
| CN1307150C (zh) | 2007-03-28 |
| RU2004136281A (ru) | 2005-07-10 |
| BR0309940A (pt) | 2005-02-09 |
| EP1506167B1 (de) | 2007-08-29 |
| WO2003095420A1 (en) | 2003-11-20 |
| HK1082946A1 (en) | 2006-06-23 |
| AU2003229734A1 (en) | 2003-11-11 |
| NZ536418A (en) | 2006-04-28 |
| IL165004A0 (en) | 2005-12-18 |
| AU2003229734B2 (en) | 2009-02-19 |
| TW200404052A (en) | 2004-03-16 |
| DE60315973D1 (de) | 2007-10-11 |
| JP4335131B2 (ja) | 2009-09-30 |
| RU2331635C2 (ru) | 2008-08-20 |
| CA2487238C (en) | 2011-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003294748A1 (en) | Tetrahydro-naphthalene derivatives | |
| WO2003055848A3 (en) | Urea derivatives as vr1- antagonists | |
| IL165004A0 (en) | Hydroxy tetrahydro-naphthalenylurea derivatives | |
| WO2003014064A8 (en) | Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists | |
| WO2009109618A3 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 | |
| WO2006059234A3 (en) | Bicyclic amides as kinase inhibitors | |
| WO2005112970A3 (en) | Use of gelsolin to treat infections | |
| WO2009109616A8 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 | |
| AU2003288200A1 (en) | Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists | |
| WO2009109654A8 (en) | 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1 | |
| WO2006074265A3 (en) | Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders | |
| WO2007053495A3 (en) | Compounds useful as antagonists of ccr2 | |
| WO2011045068A3 (en) | Pharmaceutical composition containing cannabinoid-receptor 2 antagonists | |
| GB2427405A (en) | Novel hydroxamates as therapeutic agents | |
| WO2005044802A3 (en) | Tetrahydro-quinolinylurea derivatives as vrl antagonists | |
| WO2007140181A3 (en) | Combination therapy comprising an adenosine uptake inhibitor and a non-selective adenosine receptor antagonist | |
| WO2007053499A3 (en) | Compounds useful as antagonists of ccr2 | |
| MY155011A (en) | Hydroxy tetrahydro-naphthalenylurea derivatives | |
| WO2007062862A3 (en) | Use of calmodulin inhibitors for the treatment of neurodegenerative disorders | |
| WO2012060594A3 (ko) | 티오우레아계 화합물 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 항염증 조성물 | |
| TW200716629A (en) | Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof | |
| WO2006090376A3 (en) | Pharmaceutical compositions of the isolated d- enantiomer of the quinazolinone derivative halofuginone | |
| UY27794A1 (es) | Derivados de hidroxi tetrahidro-naftalenilurea | |
| TH78306A (th) | อนุพันธ์ไฮดรอกซีเททตราไฮโดร-แนพธาลีนิลยูเรีย | |
| TH78306B (th) | "อนุพันธ์ไฮดรอกซีเททตราไฮโดร-แนพธาลีนิลยูเรีย" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20110426 Year of fee payment: 9 |
|
| OBST | Application withdrawn |